Use of gene tests to detect hereditary predisposition to cancer: What do we know about cost effectiveness?

International Journal of Cancer

Volumn 69, Issue 1, 1996, Pages 55-57

  Brown, Martin L ^a   Kessler, Larry G ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER; CANCER SCREENING; COLON CANCER; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; GENETIC SCREENING; HUMAN; INHERITANCE; PRIORITY JOURNAL;

COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; COST-BENEFIT ANALYSIS; GENETIC SCREENING; HUMANS; PREDICTIVE VALUE OF TESTS; RISK FACTORS;

EID: 0029920003     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960220)69:1<55::AID-IJC14>3.0.CO;2-J     Document Type: Conference Paper

References (18)

1. BROWN, M.L. and FINTOR, L., Cost-effectiveness of breast cancer screening: preliminary results of a systematic review of the literature. Breast Cancer Res. Treat., 25, 113-118 (1993).
2. BYERS, T. and GORSKY, R., Estimates of costs and effects of screening for colorectal cancer in the United States. Cancer, 70 (Suppl.), 1288-1295 (1992).
3. FIREMAN, B., QUESENBERRY, C., SOMKIN, C., JACOBSON, A., BAER, D. and WEST, D., The cost of care for cancer in a health maintenance organization. Kaiser Permanente. Final Report (Contract NO1-CN-05224), Applied Research Branch, National Cancer Institute, Bethesda, MD (1994).
4. FISHEL, R., LESCOE, M.K., RAO, M.R.S., COPELAND, N.G., JENKINS, N.A., GARBER, J., KANE, M. and KOLODNER, R., The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, 75, 1027-1038 (1993).
5. JACOBY, R.F., KAILAS, S., MARSHALL, D.J. and HARMS. B., Genetic analysis and implications for screening in hereditary nonpolyposis colon cancer. Gastroenterology, 106, A398 (1994).
6. LANSPA, S.J., JENKINS, J.X., WATSON, P., SMYRK, T C., CAVALIERI, R.J., LYNCH, J.F. and LYNCH, H.T., Natural history of at-risk Lynch syndrome family members with respect to adenomas. Nebraska med. J., 77, 310-313 (1992).
7. LIEBERMAN, D., Cost-effectiveness of colon cancer screening. Amer. J. Gastroenterol., 86, 1789-1794 (1991).
8. LYNCH, P., Hereditary nonpolyposis colorectal carcinoma (HNPCC): clinical application of molecular diagnostic testing. Ann. Med., 26, 221-228 (1994).
9. LYNCH, H.T. and LYNCH, J.F., The Lynch syndromes. Curr. Opin. Oncol., 5, 687-696 (1993).
10. LYNCH, H.T., SMYRK, T.C., CAVALIERI, R.N. and LYNCH, J.F., Identification of an HNPCC family. Amer. J. Gastroenterol., 89, 605-609 (1994).
11. MILLER, B.A., RIES, L.A.G., HANKEY, B.F., KOSARY, C.L., HARRAS, A., DEVESA, S.S. and EDWARDS, B.K. (EDS.), SEER cancer statistics review: 1973-1990, National Cancer Institute, NIH Publ. 93-2789, Bethesda, MD (1993).
12. NICOLAIDES, N.C. and 17 OTHERS, Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature (Lond.), 371, 75-80 (1994).
13. OFFICE OF TECHNOLOGY ASSESSMENT. The implications of costeffectiveness analysis of medical technology. Office of Technology Assessment, Washington, D.C. (1980).
14. OFFICE OF TECHNOLOGY ASSESSMENT, Costs and effectiveness of colorectal cancer screening in the elderly: background paper. U.S. Government Printing Office, Publication (OTA)BP-H-74, Washington, D.C. (1990).
15. PONZ DE LEON, M., Prevalence of hereditary nonpolyposis colorectal carcinoma. Ann. Med., 26, 209-214 (1994).
16. VASEN, H.F.A., DEN RARTOG-JAGER, F.C.A., MENKO, F.H. and NAGENGAST, F.M., Screening for hereditary non-polyposis colorectal cancer: a study of 22 kindreds in the Netherlands. Amer. J. Med., 86, 278-281 (1989).
17. VASEN, H.F., MECKLIN, J.P., WATSON, P., UTSUNOMIYA, J., BERTARIO, L., LYNCH, P., SVENDSEN, L.B., CRISTOFARO, G., MULLER, H., KHAN, P.M. and LYNCH, H.T., (The International Collaborative Group on HNPCC), Surveillance in hereditary nonpolyposis colorectal cancer: an international cooperative study of 165 families. Dis. Colon Rectum, 36, 1-4 (1993).
18. VASEN, H.F., TAAL, B.G., GRIFFLOEN, G., NAGENGAST, F.M., CATS, A., MENKO, F.H., OSKAM, W., KLEIBEUKER, J.H., OFFERHAUS, G.J.A. and KHAN, P.M., Clinical heterogeneity of familial colorectal cancer and its influence on screening protocols. Gut, 35, 1262-1266 (1994).